维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="CLAVIO M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study显示文摘	BALLEARI E ROSSI E CLAVIO M	2006	Ann Hematol2006，85，：	1
	2	Unusual intracellular and ex- tracellular crystal inclusions in light chain multiple myeloma 显示文摘	Casciaro S Clavio M Boccaccio P	1999	Haematologica1999，84，11：	1
	3	High efficacy of fludarabine-containingtherapy (FLAG-FLANG) in poor risk acute myeloid leukemia显示文摘	CLAVIO M CARRARA P MIGLINO M	1996	Haematologica1996，81，6：	1
	4	Modulation of ovarian function in female dogs immunized with bovine luteinizing hormone receptor显示文摘	Saxena BB Clavio A Singh M	2002	Reprod Domest Anim2002，37，1：	1
	5	High efficacy of fludarabine containing therapy(FLAG,FLANG) in poor risk acute myeloid leukemia显示文摘	Clavio M Carrara P Miglino M	1996	Haematologica1996，81，：	1
	6	Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients With non-M3 acute myeloid leukaemia: results of a prospective, pilot, muhi-centre trial and comparison with a historical cohort of patients 显示文摘	CLAVIO M VIGNOLO L ALBARELLO A	2007	Br J Haematol2007，138，2：	1
	7	Multiple myeloma in the elderly: Clinical features and response to treatment in 113 patient显示文摘	Clavio M Casciaro S Gatti AM	1996	Haematologica1996，81，：	1
	8	Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes 显示文摘	Balleari E Clavio M Arboscello E	2011	Leuk Res2011，35，11：	1
	9	First line fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual diseaes显示文摘	Clavio M Miglino M Spriano M	1998	Eur J Haematol1998，61，3：	1
	10	High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia 显示文摘	CLAVIO M CARRARA P MIGLINO M	1996	Haernatologica1996，81，6：	1
	11	Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate l risk myelodysplastic syndromes显示文摘	Balleari E Clavio M Arboscello E		0，，11：	1
	12	De novo AML patients with favourable-intermediate karyotype may benefit from the addition of lowdose gemtuzumab ozogamicin(GO) to fludarabine,Ara-C and idanubicin(FLAI):a contribution to the reopened 'GO question'显示文摘	Clavio M Cruciani F Minetto P		0，，10：	1
	13	Anaplastic large cell lymphoma: A clinicopathologic study of 53 patients 显示文摘	Rossi E Truini M	1996	Leukemia and lymphoma1996，22，：	1
	14	Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report显示文摘	CLAVIO M NOBILI F BALLEARI E	2004	Eur J Haematol2004，72，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费